RecruitingNot applicableNCT06177938
Lactobreath: A Study to Diagnose Lactose Intolerance Using Breath Markers
Studying Genetic intestinal disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ETH Zurich
- Intervention
- Lactose solution/Glucose solution(dietary_supplement)
- Enrollment
- 120 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2024 – 2025
Study locations (1)
- ETH Zurich, Zurich, Canton of Zurich, Switzerland
Collaborators
Agroscope Liebefeld-Posieux Research Station ALP · Swiss Allergy Centre · University of Zurich
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06177938 on ClinicalTrials.govOther trials for Genetic intestinal disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05398380Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational ResearchHospital Vall d'Hebron
- ACTIVE NOT RECRUITINGNANCT07555639An Integrated Genomic Approach to Assess Genetic Risk and Drug SensitivityFondazione Policlinico Universitario Agostino Gemelli IRCCS
- ACTIVE NOT RECRUITINGNCT04157322Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal MetastasisUniversity of Chicago
- RECRUITINGNCT06096688Discovering New Targets for Colorectal and Endometrial Cancer Risk ReductionWeill Medical College of Cornell University
- ACTIVE NOT RECRUITINGNCT04087239The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT StudyUniversity of Zimbabwe